Biomerica, Inc. (BMRA)
2.142
-0.09
(-4.17%)
USD |
NASDAQ |
Oct 02, 16:00
2.15
+0.01
(+0.37%)
After-Hours: 20:00
Biomerica Enterprise Value : 7.919M for Oct. 2, 2026
Enterprise Value Chart
Historical Enterprise Value Data
| Date | Value |
|---|---|
| October 02, 2026 | 7.919M |
| October 01, 2026 | 8.218M |
| September 30, 2026 | 8.296M |
| September 29, 2026 | 8.424M |
| September 28, 2026 | 8.711M |
| September 25, 2026 | 8.488M |
| September 24, 2026 | 8.935M |
| September 23, 2026 | 9.399M |
| September 22, 2026 | 9.958M |
| September 21, 2026 | 9.383M |
| September 18, 2026 | 9.095M |
| September 17, 2026 | 8.616M |
| September 16, 2026 | 8.648M |
| September 15, 2026 | 8.424M |
| September 14, 2026 | 8.616M |
| September 11, 2026 | 8.232M |
| September 10, 2026 | 8.200M |
| September 09, 2026 | 8.312M |
| September 08, 2026 | 8.552M |
| September 04, 2026 | 8.456M |
| September 03, 2026 | 8.169M |
| September 02, 2026 | 8.105M |
| September 01, 2026 | 7.753M |
| August 31, 2026 | 7.753M |
| August 28, 2026 | 7.913M |
| Date | Value |
|---|---|
| August 27, 2026 | 7.785M |
| August 26, 2026 | 6.475M |
| August 25, 2026 | 6.731M |
| August 24, 2026 | 6.443M |
| August 21, 2026 | 6.219M |
| August 20, 2026 | 6.140M |
| August 19, 2026 | 5.932M |
| August 18, 2026 | 6.188M |
| August 17, 2026 | 6.060M |
| August 14, 2026 | 6.124M |
| August 13, 2026 | 6.251M |
| August 12, 2026 | 6.092M |
| August 11, 2026 | 6.092M |
| August 10, 2026 | 6.283M |
| August 07, 2026 | 6.219M |
| August 06, 2026 | 6.188M |
| August 05, 2026 | 6.251M |
| August 04, 2026 | 5.964M |
| August 03, 2026 | 5.964M |
| July 31, 2026 | 5.836M |
| July 30, 2026 | 6.155M |
| July 29, 2026 | 6.156M |
| July 28, 2026 | 6.188M |
| July 27, 2026 | 6.252M |
| July 24, 2026 | 6.140M |
Enterprise Value Definition
EV is considered the theoretical purchase ("takeover") price of a business because a purchaser would take on the company's debt, while pocketing the company's cash and gaining a right to all of the company's future earnings.
Enterprise Value Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Enterprise Value Benchmarks
| Univec, Inc. | 6.020M |
| Lantheus Holdings, Inc. | 6.556B |
| Zomedica Corp. | 34.99M |
| IDEXX Laboratories, Inc. | 41.79B |
| Neogen Corp. | 3.272B |
Enterprise Value Related Metrics
| Net Income (Quarterly) | -1.145M |
| Revenue (Quarterly) | 0.875M |
| Total Expenses (Quarterly) | 2.02M |
| EPS Diluted (Quarterly) | -0.3729 |
| Gross Profit Margin (Quarterly) | -8.11% |
| Profit Margin (Quarterly) | -130.9% |
| Earnings Yield | -58.91% |
| Normalized Earnings Yield | -62.47 |